Paragonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”

Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research…

Continue ReadingParagonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”

Paragonix Technologies Presenting New Organ Preservation Research at the International Society of Heart and Lung Transplantation 2022 Annual Meeting

Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research…

Continue ReadingParagonix Technologies Presenting New Organ Preservation Research at the International Society of Heart and Lung Transplantation 2022 Annual Meeting

Paragonix SherpaPak featured in KMTV News segment “Glenwood man is first-ever SherpaPak heart transplant recipient”

https://youtu.be/Ja5MzXpjbLA From KMTV News Now Omaha OMAHA, Neb. (KMTV) — Looking at him, you might not know Tim Hagen is one in 7.9 billion. "When they found the cancer, the…

Continue ReadingParagonix SherpaPak featured in KMTV News segment “Glenwood man is first-ever SherpaPak heart transplant recipient”

University of Virginia Medical Center Completes First Successful Transplant Using the Paragonix SherpaPak® Cardiac Transport System

CAMBRIDGE, MASSACHUSETTS – February 8, 2022 – Paragonix Technologies announced the first successful heart transplant at the University of Virginia Medical Center using it’s SherpaPak Cardiac Transport System (CTS). The…

Continue ReadingUniversity of Virginia Medical Center Completes First Successful Transplant Using the Paragonix SherpaPak® Cardiac Transport System

Paragonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case

Device enables donor lungs to safely travel unprecedented distance of 4,788 Miles with a total ischemic time of over 13 hours CAMBRIDGE, MASSACHUSETTS – Feb. 2, 2021 – Paragonix Technologies announces…

Continue ReadingParagonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case

Legacy of Hope Performs First Time Use and Clinical Support of Advanced Preservation Technology for Thoracic and Abdominal Organs

CAMBRIDGE, MASSACHUSETTS – January 11, 2022 – Paragonix Technologies, Inc., a leading provider of donor organ preservation and transport systems, announced the first time, combination use of LIVERguard™ and Paragonix SherpaPak® to…

Continue ReadingLegacy of Hope Performs First Time Use and Clinical Support of Advanced Preservation Technology for Thoracic and Abdominal Organs

Paragonix Technologies Announces Launch of the Paragonix Web Portal, Providing Users Access to Critical Organ Preservation Data

Real-time, centralized, secure coordination and data for transplant teams to facilitate the optimization of the donation and transplantation process CAMBRIDGE, MASSACHUSETTS – January 4, 2022 – Paragonix Technologies, Inc. is announcing…

Continue ReadingParagonix Technologies Announces Launch of the Paragonix Web Portal, Providing Users Access to Critical Organ Preservation Data

Paragonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic

CAMBRIDGE, MASSACHUSETTS – Dec. 15, 2021 –  Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today the first-in-human clinical use of the only FDA cleared cold storage device…

Continue ReadingParagonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic